PTGX

78.62

0.99% 0.77

Dopo l'orario di chiusura: 77.50 -1.12 -1.42%

Protagonist Therapeutics Inc (PTGX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PTGX Giù? Forum Previsione

Precedente Chiudi:

$77.85

Aprire:

$77.53

Volume 24 ore:

723.14K

Relative Volume:

0.66

Capitalizzazione di mercato:

$4.89B

Reddito:

$209.18M

Utile/perdita netta:

$52.04M

Rapporto P/E:

110.34

EPS:

0.7125

Flusso di cassa netto:

$37.10M

1 W Prestazione:

+5.02%

1M Prestazione:

+18.35%

6M Prestazione:

+71.58%

1 anno Prestazione:

+71.51%

Intervallo 1D:

$76.66

$79.01

Intervallo di 1 settimana:

$74.03

$79.01

Portata 52W:

$33.31

$93.25

Protagonist Therapeutics Inc Stock (PTGX) Company Profile

Nome

Protagonist Therapeutics Inc

Settore

Healthcare (1135)

Industria

Biotechnology (635)

Telefono

(510) 474-0170

Indirizzo

7707 GATEWAY BLVD., SUITE 140, NEWARK, CA

Dipendente

130

Cinguettio

Prossima data di guadagno

2025-05-02

Ultimi documenti SEC

PTGX's Discussions on Twitter

Confronta PTGX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PTGX Protagonist Therapeutics Inc	78.62	4.84B	209.18M	52.04M	37.10M	0.7125
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Protagonist Therapeutics Inc Stock (PTGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-17	Iniziato	Barclays	Overweight
2025-09-12	Iniziato	Leerink Partners	Outperform
2025-06-17	Iniziato	Citigroup	Buy
2024-12-06	Iniziato	BMO Capital Markets	Outperform
2024-12-06	Iniziato	Goldman	Neutral
2024-11-05	Iniziato	Wedbush	Outperform
2024-09-24	Iniziato	TD Cowen	Buy
2024-09-09	Iniziato	Truist	Buy
2023-10-30	Iniziato	CapitalOne	Overweight
2023-05-25	Ripresa	Jefferies	Buy
2022-08-25	Iniziato	JMP Securities	Mkt Outperform
2022-02-11	Iniziato	BTIG Research	Buy
2021-10-12	Aggiornamento	JP Morgan	Neutral → Overweight
2021-10-11	Aggiornamento	Northland Capital	Market Perform → Outperform
2021-09-20	Downgrade	JP Morgan	Overweight → Neutral
2021-05-24	Iniziato	JMP Securities	Mkt Outperform
2021-05-24	Iniziato	Northland Capital	Outperform
2021-01-06	Iniziato	JP Morgan	Overweight
2020-12-16	Iniziato	Piper Sandler	Overweight
2020-09-18	Reiterato	H.C. Wainwright	Buy
2020-07-15	Iniziato	Jefferies	Buy
2020-05-18	Reiterato	H.C. Wainwright	Buy
2019-07-08	Iniziato	H.C. Wainwright	Buy
2019-05-09	Aggiornamento	Stifel	Hold → Buy
2018-12-06	Iniziato	Nomura	Buy
2018-01-29	Iniziato	Stifel	Buy
2017-07-21	Iniziato	BTIG Research	Buy

Mostra tutto

Protagonist Therapeutics Inc Borsa (PTGX) Ultime notizie

02:44 AM

How strong is Protagonist Therapeutics Inc. stock revenue growth2025 Momentum Check & Safe Capital Preservation Plans - newser.com

02:44 AM

01:33 AM

Price action breakdown for Protagonist Therapeutics Inc.July 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

01:33 AM

02:59 AM

Is Protagonist Therapeutics Inc. stock entering bullish territoryStop Loss & Long-Term Safe Investment Ideas - newser.com

02:59 AM

02:35 AM

Can Protagonist Therapeutics Inc. hit a new high this month2025 Dividend Review & Weekly Market Pulse Updates - newser.com

02:35 AM

Nov 01, 2025

Is Protagonist Therapeutics Inc. stock a top pick in earnings season2025 Momentum Check & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025